tiprankstipranks
Trending News
More News >
Roche Holding (RHHBY)
OTHER OTC:RHHBY

Compare Roche Holding (RHHBY) vs. Competitors

Compare
1,631 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Roche Holding
$54.25
$347.14B
31.66
47.94%
2 Buy
3 Hold
0 Sell
Moderate Buy
AstraZeneca
$94.39
$291.63B
31.10
41.07%
5 Buy
0 Hold
0 Sell
Strong Buy
Gilead Sciences
$124.91
$154.97B
19.35
36.29%
16 Buy
3 Hold
0 Sell
Strong Buy
Merck & Company
$108.83
$270.12B
14.40
8.07%
11 Buy
5 Hold
0 Sell
Moderate Buy
Novartis
$144.34
$274.10B
19.55
47.50%
1 Buy
4 Hold
1 Sell
Hold
Sanofi
$46.59
$113.56B
11.58
-8.18%
2 Buy
3 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RHHBY
Roche Holding
54.25
18.63
52.32%
AZN
AstraZeneca
94.39
29.16
44.69%
GILD
Gilead Sciences
124.91
34.48
38.13%
MRK
Merck & Company
108.83
16.08
17.34%
NVS
Novartis
144.34
49.68
52.48%
SNY
Sanofi
46.59
-2.58
-5.25%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts